---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-060305"
form_type: "8-K"
ticker: "OTLK"
cik: "0001649989"
company_name: "Outlook Therapeutics, Inc."
filed_at: "2026-05-13T20:36:26+00:00"
generated_at: "2026-05-13T20:39:37.892062+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Outlook Therapeutics enters new $100M ATM with H.C. Wainwright; cash at $7.7M

## Summary
- Entered into $100M at-the-market offering agreement with H.C. Wainwright & Co. as sales agent.
- Prior $100M ATM with BTIG terminated effective May 12, 2026.
- Preliminary cash and cash equivalents of $7.7M as of March 31, 2026 (unaudited), plus $4.5M from April 2026 direct offering.
- H.C. Wainwright will receive a 3% commission on gross proceeds from shares sold under the ATM.

## SEC filing metadata
- accession: 0001104659-26-060305
- form_type: 8-K
- ticker: OTLK
- cik: 0001649989
- company_name: Outlook Therapeutics, Inc.
- filed_at: 2026-05-13T20:36:26+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 1.02, 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649989/000110465926060305/0001104659-26-060305-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649989/000110465926060305/tm2614480d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-060305
- JSON: https://secwatch.observer/filing/0001104659-26-060305.json
- Plain text: https://secwatch.observer/filing/0001104659-26-060305.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.